SA lab study shows next Covid strain may be more dangerous

accreditation
0:00
play article
Subscribers can listen to this article
Getty Images

A South African laboratory study using Covid-19 samples from an immunosupressed individual over six months showed that the virus evolved to become more pathogenic, indicating that a new variant could cause more illness than the current predominant omicron strain. 

The study, conducted by the same laboratory that was to first test the omicron strain against vaccines last year, used samples from a person infected with HIV. Over the six months the virus initially caused the same level of cell fusion and death as the omicron BA.1 strain, but as it evolved those levels rose to become similar to the first version of Covid-19 identified in Wuhan in China.

The study, led by Alex Sigal at the Africa Health Research Institute in the South African city of Durban, indicates that the Covid-19 pathogen could continue to mutate and a new variant may cause more severe illness and death than the relatively mild omicron strain. The study is yet to be peer reviewed and is based solely on laboratory work on samples from one individual.

Sigal and other scientists have previously postulated that variants such as beta and omicron -- both initially identified in southern Africa - may have evolved in immunosuppressed people such as those infected with HIV. The long time it takes for these individuals to shake off the disease allows it to mutate and become better at evading antibodies, they have said.

The study “may indicate that SARS-CoV-2 evolution in long-term infection does not have to result in attenuation,” the researchers said in their findings, which were released on November 24. “It may indicate that a future variant could be more pathogenic than currently circulating Omicron strains.”


We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
17.47
-2.2%
Rand - Pound
21.05
-0.0%
Rand - Euro
18.91
-0.0%
Rand - Aus dollar
12.09
-0.0%
Rand - Yen
0.13
-0.0%
Platinum
974.02
0.0%
Palladium
1,623.95
0.0%
Gold
1,865.16
0.0%
Silver
22.35
0.0%
Brent Crude
79.94
-2.8%
Top 40
74,082
+0.6%
All Share
80,241
+0.6%
Resource 10
75,186
+0.7%
Industrial 25
103,461
+0.8%
Financial 15
16,550
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders